Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT01179737 · TERMINATED
Trial details
- NCT number
- NCT01179737
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2013-01-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.